Mondesert O - Search Results

1

Prevost GP, Brezak MC, Goubin F, Mondesert O, Galcera MO, Quaranta M, Alby F, Lavergne O, Ducommun B. Prevost GP, et al. Among authors: mondesert o. Prog Cell Cycle Res. 2003;5:225-34. Prog Cell Cycle Res. 2003. PMID: 14593717 Review.

2

A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25.

Mondesert O, Lemaire M, Brezak MC, Galera-Contour MO, Prevost G, Ducommun B, Bugler B. Mondesert O, et al. Curr Genet. 2004 May;45(5):283-8. doi: 10.1007/s00294-003-0483-3. Epub 2004 Jan 15. Curr Genet. 2004. PMID: 14727060

3

A novel synthetic inhibitor of CDC25 phosphatases: BN82002.

Brezak MC, Quaranta M, Mondésert O, Galcera MO, Lavergne O, Alby F, Cazales M, Baldin V, Thurieau C, Harnett J, Lanco C, Kasprzyk PG, Prevost GP, Ducommun B. Brezak MC, et al. Among authors: mondesert o. Cancer Res. 2004 May 1;64(9):3320-5. doi: 10.1158/0008-5472.can-03-3984. Cancer Res. 2004. PMID: 15126376

4

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases.

Brezak MC, Quaranta M, Contour-Galcera MO, Lavergne O, Mondesert O, Auvray P, Kasprzyk PG, Prevost GP, Ducommun B. Brezak MC, et al. Among authors: mondesert o. Mol Cancer Ther. 2005 Sep;4(9):1378-87. doi: 10.1158/1535-7163.MCT-05-0168. Mol Cancer Ther. 2005. PMID: 16170030

5

Ability of human CDC25B phosphatase splice variants to replace the function of the fission yeast Cdc25 cell cycle regulator.

Lemaire M, Mondesert O, Bugler B, Ducommun B. Lemaire M, et al. Among authors: mondesert o. FEMS Yeast Res. 2004 Dec;5(3):205-11. doi: 10.1016/j.femsyr.2004.07.003. FEMS Yeast Res. 2004. PMID: 15556082

6

Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.

Brun MP, Braud E, Angotti D, Mondésert O, Quaranta M, Montes M, Miteva M, Gresh N, Ducommun B, Garbay C. Brun MP, et al. Among authors: mondesert o. Bioorg Med Chem. 2005 Aug 15;13(16):4871-9. doi: 10.1016/j.bmc.2005.05.005. Bioorg Med Chem. 2005. PMID: 15921913

7

Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors.

Montes M, Braud E, Miteva MA, Goddard ML, Mondésert O, Kolb S, Brun MP, Ducommun B, Garbay C, Villoutreix BO. Montes M, et al. Among authors: mondesert o. J Chem Inf Model. 2008 Jan;48(1):157-65. doi: 10.1021/ci700313e. Epub 2007 Dec 22. J Chem Inf Model. 2008. PMID: 18154280

8

Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.

Braud E, Goddard ML, Kolb S, Brun MP, Mondésert O, Quaranta M, Gresh N, Ducommun B, Garbay C. Braud E, et al. Among authors: mondesert o. Bioorg Med Chem. 2008 Oct 1;16(19):9040-9. doi: 10.1016/j.bmc.2008.08.009. Epub 2008 Aug 7. Bioorg Med Chem. 2008. PMID: 18789703

9

Human CDC25B and CDC25C differ by their ability to restore a functional checkpoint response after gene replacement in fission yeast.

Mondesert O, Ducommun B, Bugler B. Mondesert O, et al. Biochem Biophys Res Commun. 2002 Jul 19;295(3):673-7. doi: 10.1016/s0006-291x(02)00739-8. Biochem Biophys Res Commun. 2002. PMID: 12099692

10

CDC25B phosphorylation by p38 and MK-2.

Lemaire M, Froment C, Boutros R, Mondesert O, Nebreda AR, Monsarrat B, Ducommun B. Lemaire M, et al. Among authors: mondesert o. Cell Cycle. 2006 Aug;5(15):1649-53. doi: 10.4161/cc.5.15.3006. Epub 2006 Aug 1. Cell Cycle. 2006. PMID: 16861915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters